A novel peptide could provide a more targeted approach to Alzheimer’s treatment by inhibiting two key Tau protein regions.
Dual-action drug could tackle Alzheimer’s Tau aggregation
Posted in biotech/medical, neuroscience
Posted in biotech/medical, neuroscience
A novel peptide could provide a more targeted approach to Alzheimer’s treatment by inhibiting two key Tau protein regions.